Navigation Links
VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
Date:10/10/2007

(NDA) to the U. S. Food and Drug Administration (FDA) in 2007 for Lenocta(TM) for the treatment of leishmaniasis.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties that could cause VioQuest's actual results and experiences to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These forward-looking statements concern the timing, progress and results of the clinical development, regulatory processes, and potential clinical trial initiations of Lenocta. These statements are often, but not always, made through the use of words or phrases such as anticipates, expects, plans, believes, intends, and similar words or phrases. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. These statements are subject to various risks and uncertainties and include the possibility that the results of clinical trials will not support VioQuest's claims, the possibility that VioQuest's development efforts relating to its product candidates, including Lenocta(TM), will not be successful, the inability to obtain regulatory approval of VioQuest's product candidates, VioQuest's reliance on third-party researchers to develop its product candidates, its lack of experience in developing and commercializing pharmaceutical products, and the possibility that its licenses to develop and commercialize its product candidates may be terminated. Additional risks are described in VioQuest's Annual Report on Form 10-KSB for the year ended December 31, 2006. VioQuest assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contact information:

Daniel Greenleaf

President and CEO

908-766-4400 ext. 115


SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Calif. , June 19, 2013   ... today announces a licensing agreement granting Suzhou Ribo ... and manufacture siRNA therapeutics in China ...  Ribo will formulate proprietary siRNA molecules in combination ... designed to address human diseases with high unmet ...
(Date:6/19/2013)... Today MedeAnalytics, a leading provider of ... its Employer Group and Individual Business Analytics ... their employer groups an intuitive and insightful view ... drug claims, network utilization, and overall financial impact. ... "Employer Group and Individual Business Analytics ...
(Date:6/19/2013)... INDIANAPOLIS , 19. Juni 2013 ... bekannt, dass mit der Entwicklung von ... bahnbrechender Schritt in der Beschichtung mit ... die Vorteile von biokompatiblem Parylene mit ... effektive Beseitigung schädlicher Mikroorganismen auf beschichteten ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the ... branded Traditional Chinese Medicine ("TCM") consumer products, today ... Anhui Province in eastern China. The Company,s value-oriented ... "Yang Yang Ba" health drink are now available ...
... Mass., May 7, 2011 Objet Geometries Ltd. , ... rapid prototyping and additive manufacturing, will demonstrate the benefits ... DAY West. Exhibiting at Booth B6, B-7, Objet will present ... the show on the Objet Eden260V™ 3D printing system. ...
Cached Medicine Technology:Nutrastar Distribution Spreads into Anhui Province 2Nutrastar Distribution Spreads into Anhui Province 3Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 2Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 3Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 4
(Date:6/19/2013)... June 19, 2013 Brand new Hypertrophy Max bonus ... 4 day sale on the Hypertrophy Max program. Vince and ... hours so those that are interested must act quickly. , What ... Hypertrophy Max bonus is a free 12 month all access pass ... According to Ryan Davids "Live Large TV is a Monday night ...
(Date:6/19/2013)... 19, 2013 The Zac Brown Band ... country and folk music genre. This band hails from Atlanta, ... lead vocals and guitarist), Jimmy De Martini (working with fiddle ... and in vocals), Coy Bowles (guitarist and keyboardist), Chris Fryar ... The band was formed in 2002, but they gained ...
(Date:6/19/2013)... A man returning from war is not likely to return home ... book titled RED DANCER JOURNEY, author Rafael Fraguada pens a compelling ... for the right place and people to mend his traumatized life. ... Vietnam War, returns to New York City, he meets up with ... wealthy acquaintance from a tiny Midwest college they both had attended, ...
(Date:6/19/2013)... NC (PRWEB) June 19, 2013 As ... has partnered with Brookstone Lodge on some summertime packages. ... or locals are looking for a fun staycation, we ... fun for couples and families. Asheville is so beautiful ... enjoy, so having several options that guests can choose ...
(Date:6/19/2013)... WV (PRWEB) June 19, 2013 The ... individual used the sauna but the overall experience for ... to be positive health-wise. , Mr Mouw, whose Virgina-based ... to the Society’s statement by saying that the type ... learned of a number of counterfeit imitations which frankly, ...
Breaking Medicine News(10 mins):Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:Zac Brown Band Tickets for Raleigh, Columbia, Darien Center, Gilford, Minneapolis, Holmdel, Pittsburgh, Camden, Atlanta, Boston, Bethel, Toronto & Hartford Now Available 2Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2
... for a child. But stress and fear, and the ... reduced with simple means: drawings, continuity and dialogue. This ... at the University of Gothenburg, Sweden. Berith Wennstrm ... they experienced being in hospital and undergoing surgery. The ...
... Dotinga HealthDay Reporter , TUESDAY, Dec. 20 ... training, which teaches people to push away troublesome thoughts, ... similar diseases. Patients in Norway who received the ... who didn,t receive the training, but researchers found they ...
... Discovery Campaign, which seeks to further the growth ... discovery, announced a major corporate pledge to that ... and laboratory diagnostic equipment and information technology and ... pledged $200,000, as a "Pioneer" Supporter. ...
... with spirits drinkers, have been shown to have higher ... diet, be more physically active, and have other characteristics ... epidemiologic studies have been inconsistent in showing that, after ... have lower risk of cardiovascular disease and mortality than ...
... Calif. -- A program for women at risk of ... annually in health care costs if implemented nationwide, according ... American College of Obstetricians and Gynecologists, journal, Obstetrics ... the Kaiser Permanente Early Start program follows a 2008 ...
... Medicine received a $6.75 million Program Project Grant from ... Diseases (NIDDK) to study the role of innate immunity ... focused their attention on the role of lymphocytes and ... disease, a chronic debilitating disease affecting more than one ...
Cached Medicine News:Health News:Different methods can reduce hospital fear in children 2Health News:Mindfulness Training May Help Arthritis Patients Cope 2Health News:Study finds Kaiser Permanente Early Start program could save US billions in health costs 2Health News:$6.75 million awarded to Case Western Reserve to study IBD 2
... 1 Block MBS Start up kit. ... software and choice of 1 MultiBlock ... to 30 blocks. User friendly software. ... Adjustable height heated lid. Outstanding ...
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... The latest addition to our ... cyclers is the personal-sized GeneAmp ... instrument for both basic PCR ... represents the culmination of several ...
Medicine Products: